Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Caladrius Bio (NQ: CLBS ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 14, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Caladrius Bio < Previous 1 2 Next > Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday September 15, 2022 Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session September 14, 2022 Via Benzinga Caladrius Biosciences Stops Enrollment In Mid-Stage Heart Disease Study May 24, 2022 Via Benzinga Caladrius Biosciences To Merge With Privately-Held Cend Therapeutics April 27, 2022 Via Benzinga Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session September 14, 2022 Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session September 02, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday September 02, 2022 We're starting off the final trading day of the week with an overview of the biggest pre-market stock movers for Friday! Via InvestorPlace Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket September 02, 2022 Gainers Via Benzinga Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial August 10, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Outlook For Caladrius Biosciences August 03, 2022 Caladrius Biosciences (NASDAQ:CLBS) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga Caladrius Biosciences's Earnings Outlook August 03, 2022 Caladrius Biosciences (NASDAQ:CLBS) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary August 02, 2022 Via Benzinga The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures May 24, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 28 Stocks Moving in Thursday's Pre-Market Session April 28, 2022 Gainers T Stamp Inc. (NASDAQ: IDAI) shares rose 103.3% to $4.27 in pre-market trading after gaining over 8% on Wednesday. Trust Stamp recently posted Q4 net sales of $2.1... Via Benzinga 74 Biggest Movers From Yesterday April 29, 2022 Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric... Via Benzinga The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis April 27, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga 48 Stocks Moving In Thursday's Mid-Day Session April 28, 2022 Gainers T Stamp Inc. (NASDAQ: IDAI) shares jumped 201% to $6.33. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric MFATM) solution. Statera... Via Benzinga The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale March 23, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga Recap: Caladrius Biosciences Q4 Earnings March 23, 2022 Caladrius Biosciences (NASDAQ:CLBS) reported its Q4 earnings results on Tuesday, March 22, 2022 at 04:30 PM. Here's what investors need to know about the announcement.... Via Benzinga The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout March 22, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Scheduled For March 22, 2022 March 22, 2022 Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is projected to report quarterly loss at $0.18 per share on revenue of $338.69 million. • HUYA (... Via Benzinga Caladrius Biosciences Earnings Preview March 21, 2022 Caladrius Biosciences (NASDAQ:CLBS) is set to give its latest quarterly earnings report on Tuesday, 2022-03-22. Here's what investors need to know before the announcement.... Via Benzinga The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings March 20, 2022 Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session February 18, 2022 Gainers HOOKIPA Pharma (NASDAQ:HOOK) stoc... Via Benzinga 21 Stocks Moving in Wednesday's Pre-Market Session January 05, 2022 Gainers Wejo Group Ltd (NASDAQ: WEJO) rose 37% to $8.63 in pre-market trading after the company announced a new connected vehicle platform with Microsoft, called Wejo Neural Edge... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session January 04, 2022 Gainers Hoth Therapeutics (NASDAQ: Via Benzinga 5 Penny Stocks Insiders Are Buying December 13, 2021 When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste... Via Benzinga The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO November 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... Via Benzinga Exposures COVID-19 The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results October 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.